Bayer bets on ‘silver bullet’ defense in Monsanto Roundup cancer litigation

  • Home
  • Bayer bets on ‘silver bullet’ defense in Monsanto Roundup cancer litigation

Bayer bets on ‘silver bullet’ defense in Monsanto Roundup cancer litigation

Posted by The Analyst | May 17, 2019 | Business
Preview

German pharmaceutical firm Bayer plans to argue that a $2 billion jury award and thousands of US lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be dropped.
Read Full Article at RT.com

Read more here:: Bayer bets on ‘silver bullet’ defense in Monsanto Roundup cancer litigation

      

Related Blogs

No Image
Posted by The Analyst | February 22, 2021
Russian e-commerce market posts explosive growth during Covid pandemic
Online shopping was booming in Russia last year, with trade volumes increasing by nearly 60 percent compared to 2019, according to a business group representing major online retailers operating in...
30 Likes
No Image
Posted by The Analyst | February 22, 2021
What a twist! Bitcoin investments bring Tesla more returns than sales of electric vehicles
Investing in bitcoin has already yielded US electric car producer Tesla its first gains of around $1 billion. The figure leaves the company's profits from selling its electric vehicles (EV)...
34 Likes
No Image
Posted by The Analyst | February 22, 2021
Russia-Germany trade turnover falls to lowest level in 16 years
The volume of trade between Russia and Germany declined by 22.2 percent in 2020, year-on-year, to €44.9 billion ($54.4 billion), according to data from the German Committee on Eastern European...
31 Likes